Tim Kutzkey

Companies

• Surrozen, Inc./DEBoard member Aug 16, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SSurrozen, Inc./DE SRZN344,827 shares²$8.6M at $24.85Jan 20, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 3, 2026Bought 89,200 shares at $11.56 of Eikon Therapeutics, Inc.³
• Jan 20, 2026Bought 9,568 shares at $19.60 of Surrozen, Inc./DE²
• Jan 20, 2026Bought 8,484 shares at $19.60 of Surrozen, Inc./DE²
• Jan 16, 2026Bought 1,358 shares at $20.00 of Surrozen, Inc./DE²
• Jan 16, 2026Bought 1,204 shares at $20.00 of Surrozen, Inc./DE²
• Jan 15, 2026Bought 6,303 shares at $19.89 of Surrozen, Inc./DE²
• Jan 15, 2026Bought 5,590 shares at $19.89 of Surrozen, Inc./DE²
• Jan 14, 2026Bought 2,927 shares at $19.99 of Surrozen, Inc./DE⁴
• Jan 14, 2026Bought 2,596 shares at $19.99 of Surrozen, Inc./DE⁴
• Jan 13, 2026Bought 6,609 shares at $19.80 of Surrozen, Inc./DE⁴
• Jan 13, 2026Bought 5,861 shares at $19.80 of Surrozen, Inc./DE⁴
• Jan 6, 2026Bought 8,003 shares at $19.89 of Surrozen, Inc./DE⁵
• Jan 6, 2026Bought 7,097 shares at $19.89 of Surrozen, Inc./DE⁵
• Dec 5, 2025Bought 16,381 shares at $19.54 of Surrozen, Inc./DE⁶
• Dec 5, 2025Bought 14,503 shares at $19.54 of Surrozen, Inc./DE⁶
• Dec 4, 2025Bought 2,791 shares at $17.35 of Surrozen, Inc./DE⁶
• Dec 4, 2025Bought 2,475 shares at $17.35 of Surrozen, Inc./DE⁶
• Nov 13, 2025Bought 167,307 shares at $12.65 of Surrozen, Inc./DE⁷
• Nov 13, 2025Bought 148,150 shares at $12.65 of Surrozen, Inc./DE⁷
• Apr 5, 2024Other 1,000 shares of NGM Biopharmaceuticals (United States)⁸
• Apr 5, 2024Returned to company 44,000 shares of NGM Biopharmaceuticals (United States)⁸
• Apr 5, 2024Returned to company 15,000 shares of NGM Biopharmaceuticals (United States)⁸
• Apr 5, 2024Returned to company 100,000 shares of NGM Biopharmaceuticals (United States)⁸
• Apr 5, 2024Returned to company 100,000 shares of NGM Biopharmaceuticals (United States)⁸
• Apr 5, 2024Returned to company 1,298,908 shares of NGM Biopharmaceuticals (United States)⁸